Focada exclusivamente no desenvolvimento, 
                                        produção e promoção de produtos farmacêuticos especializados

Notice to the Market – Alienation of Relevant Interest – JP Morgan Chase


Luxembourg, August 09th 2017 – In accordance with CVM Instruction 358/2002, as amended, BIOTOSCANA INVESTMENTS S.A. (“GBT”) hereby informs its shareholders and the market in general that it received a correspondence communicating that on August 8, 2017 JP Morgan Chase & Co (“JP Morgan”) settled the loan agreement related to the Brazilian Depositary Receipts (“BDRs”) issued by GBT.

Said investors’ interest reduced from 5.81% to 0.00% of the BDRs issued by GBT.

The Company‘s transactions with BDRs object of this notice were carried out due to J.P. Morgan‘s acting as a stabilizing agent in the scope of the IPO and do not intend to change the Company‘s control or administrative structure.
No additional information regarding the transaction was received from said investor.

Claudio Coracini
Legal Representative in Brazil

To access the notice to the market in PDF format, click here.

Updated on 01/02/2019 at 04:59 pm